EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The luteal breast hormonal and sonographic investigation of benign breast disease in patients with cyclic mastalgia


, : The luteal breast hormonal and sonographic investigation of benign breast disease in patients with cyclic mastalgia. Fertility & Sterility 40(6): 779-784

The pathophysiology, malignant potential and hormonal therapy for benign breast disease remain controversial. The anatomic and endocrinologic correlates of luteal phase mastodynia patients, compared with asymptomatic control subjects, are investigated. Objective sonographic evidence of fibrocystic disease (FCD) was found in 1/2 of both mastodynia and control groups. Endocrine abnormalities observed in the mastodynia group included significantly lower luteal phase progesterone and prolactin hyperresponsivenss to TRF. The presence or absence of anatomic FCD was not correlated with endocrine abnormalities. Cyclic mastalgia may be the end result of a dyshormonal milieu resembling the inadequate luteal phase, FCD may be hormonally independent and cyclic mastalgia and FCD are different, if often co-existent, factors in benign breast disease syndromes.


Accession: 006712454

PMID: 6653797

DOI: 10.1016/s0015-0282(16)47479-0

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Parlati, E.; Travaglini, A.; Liberale, I.; Menini, E.; Dell'Acqua, S., 1988: Hormonal profile in benign breast disease. Endocrine status of cyclical mastalgia patients. Plasma levels of prolactin, before and after TRH stimulation, progesterone, estradiol, sex-hormone-binding-globulin, androstenedione, testosterone and dehydroepiandrosterone-sulphate were determined in a group of women with benign breast disease a...

Leonardi, M., 1997: Hormonal contraception and benign breast disease. Evaluation of a treatment protocol for chronic mastopathy with mastalgia. The aim of this study was to study patients suffering from mammary nodules, fibrocystic disease and mastodynia. Having established the absence of malignant disease, the effect of EP (oestroprogestin) was evaluated in the treatment of fibrocystic d...

Marchesoni D.; Gangemi M.; Mozzanega B.; Nardelli G.B.; Maggino T.; Velasco M., 1983: Hormonal investigation in benign breast disease. Angeli, A , H L Bradlow And L Dogliotti (Ed ) Endocrinology Of Cystic Breast Disease Xviii+325p Raven Press: New York, N Y , Usa Illus P145-148

Sitruk-Ware, R.; Sterkers, N.; Mauvais-Jarvis, P., 1979: Benign breast disease I: hormonal investigation. One hundred eighty-four patients with benign breast disease (BBD) were studied and compared with 50 normal women. All of the women had ovulatory cycles according to a biphasic basal body temperature and a plasma prolactin in the normal range. Thei...

Sitruk Ware R.; Sterkers N.; Mauvais Jarvis P., 1979: Benign breast disease part 1 hormonal investigation. Patients [184] with benign breast disease (BBD) were studied and compared with 50 normal women. All of the women had ovulatory cycles according to a biphasic basal body temperature and a plasma prolactin in the normal range. Their corpus luteum fu...

Fentiman, I.S.; Hamed, H., 1995: Benign breast disease Who and how to treat for mastalgia. Figueira Fo, A S S , Novais-Dias, E , Salvador-Silva, H M , Barros, A C S D International Congress Series; Mastology: Breast diseases 10-11

Read, G.F.; Bradley, J.A.; Wilson, D.W.; George, W.D.; Griffiths, K., 1985: Evaluation of luteal-phase salivary progesterone levels in women with benign breast disease or primary breast cancer. Salivary progesterone concentrations were determined in premenopausal parous women with a mean age of ca. 40 yr who had a history of either benign breast disease (n = 15) or primary breast cancer (n = 15) and in a group of age-matched healthy wome...

Lagiou, P.; Samoli, E.; Lagiou, A.; Zourna, P.; Barbouni, A.; Georgila, C.; Tsikkinis, A.; Vassilarou, D.; Minaki, P.; Sfikas, C.; Spanos, E.; Trichopoulos, D., 2014: A comparison of hormonal profiles between breast cancer and benign breast disease: a case-control study. Benign breast disease (BBD), particularly proliferative BBD, is an established breast cancer risk factor. However, there has been no systematic attempt to compare the hormonal profiles of the two conditions. In a case–control investigation i...

Santen, R.J., 2000: Hormonal regulation of the normal breast and of benign breast disease. Hormone Research (Basel) 53(Suppl 2): 4, July

Olsson H.; Landin Olsson M.; Gullberg B., 1983: Retrospective assessment of menstrual cycle length in patients with breast cancer patients with benign breast disease and women without breast disease. The length of the menstrual cycle was compared in women with breast cancer, women with benign breast disease and controls. Older women in general tended to report shorter menstrual cycles (P < 0.05). After correction for the age difference, bre...